EuroVacc Foundation
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.eurovacc.org
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial
Phase 1
Completed
- Conditions
- HIV/AIDS
- First Posted Date
- 2018-01-05
- Last Posted Date
- 2019-02-07
- Lead Sponsor
- EuroVacc Foundation
- Target Recruit Count
- 49
- Registration Number
- NCT03391375
- Locations
- 🇺🇬
Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), Entebbe, Uganda
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
Phase 1
Completed
- Conditions
- HIV/AIDS
- First Posted Date
- 2015-03-03
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- EuroVacc Foundation
- Target Recruit Count
- 72
- Registration Number
- NCT02376582
- Locations
- 🇺🇬
Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI), Entebbe, Uganda
🇺🇬Medical Research Council (MRC) /Uganda Virus Research Institute (UVRI), Masaka, Uganda
News
No news found